Randomized phase III study comparing the first-line chemotherapy regimens in patients with driver mutation-negative advanced non-small cell lung cancer and poor performance status complicated with chronic obstructive pulmonary disease

BACKGROUND: Patients with non-small cell lung cancer (NSCLC) complicated with chronic obstructive pulmonary disease (COPD) with poor performance status (PS) are common in clinical practice with few related studies. Present studies have found that weekly low-dose docetaxel or gemcitabine combined wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Guoying, Zhou, Chengzhi, Huang, Yucheng, Hong, Ziying, Yu, Pei, Chen, Ying, Gao, Jiabo, Zhang, Kening, Xie, Zhanhong, Zhang, Jiexia, Li, Shiyue, Masashi, Nagata, Qin, Yinyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264331/
https://www.ncbi.nlm.nih.gov/pubmed/34295663
http://dx.doi.org/10.21037/tlcr-21-371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264331/
https://www.ncbi.nlm.nih.gov/pubmed/34295663
http://dx.doi.org/10.21037/tlcr-21-371

Ejemplares similares